KLP Kapitalforvaltning’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-20,900
Closed -$387K – 2176
2025
Q3
$387K Hold
20,900
– – ﹤0.01% 1527
2025
Q2
$334K Sell
20,900
-1,900
-8% -$33.9K ﹤0.01% 1554
2025
Q1
$443K Buy
22,800
+8,800
+63% +$185K ﹤0.01% 1366
2024
Q4
$308K Buy
+14,000
New +$269K ﹤0.01% 1629

Other funds holding CLBT

KLP Kapitalforvaltning's CLBT Position: Q4 2025 in Review

KLP Kapitalforvaltning sold out of Cellebrite (CLBT) in Q4 2025, closing a stake of 20,900 shares — an estimated $387K sold.

KLP Kapitalforvaltning first reported a position in CLBT in Q4 2024 and held it in 4 quarters. The position peaked at $443K in Q1 2025. 209 funds tracked by Wall St. Rank hold CLBT as of Q4 2025.

  • KLP Kapitalforvaltning reported no remaining Cellebrite position as of Q4 2025 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 20,900 Cellebrite shares in Q4 2025, an estimated $387K.
  • KLP Kapitalforvaltning first reported a position in Cellebrite in Q4 2024 and held it in 4 quarters.
  • KLP Kapitalforvaltning's Cellebrite position peaked at $443K in Q1 2025.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q4 2025.

Based on KLP Kapitalforvaltning's 13F filing for Q4 2025, filed 28 Jan 2026.